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Transcutaneous Bilirubin in Exclusively Breastfed
Healthy Term Newborns Up to 12 Days of Life
WHAT’S KNOWN ON THIS SUBJECT: Total bilirubin values
increase up to the fourth to sixth days of life in breastfed term
newborns, but it is not known when the decrement occurs.
WHAT THIS STUDY ADDS: In half of exclusively breastfed term
newborns, transcutaneous bilirubin values returned to the 24-
hour level of 4.8 mg/dL on the sixth day, but values higher than
8.5 mg/dL were still seen in 5% of neonates at day 12 after birth.
abstract
OBJECTIVE: To determine the curve of transcutaneous bilirubin in
breastfed term neonates up to 12 days of life.
METHODS: In a prospective cohort study, we performed a 12-day eval-
uation of 223 healthy, exclusively breastfed, appropriate-for-
gestational-age neonates who roomed-in for at least 48 hours. Each
newborn had forehead transcutaneous bilirubin and body weight mea-
sured at the end of 1, 2, 3, 4, 5, 6, 8, 10, and 12 days. Regression analysis
was used with bilirubin as a third-degree polynomial function of time.
The 25th, 50th, 75th, 90th, and 95th percentile curves were constructed
by using the residual mean square for each day.
RESULTS: Patients were 46% white, 34% mixed race, and 20% black,
the mean birth weight was 3260 g (range: 2560–4090 g), the mean
gestational age was 39.4 weeks (range: 37.0–41.9 weeks), 51% were
male, 74% were born by vaginal delivery, and 66% had been breastfed
since delivery. The mean highest weight loss was 4.7% (range: 1%–
12%) at the second or third day, and in most infants the weight re-
turned to the birth weight at the ﬁfth day. With 2007 total bilirubin
measurements, bilirubin concentrations reached the 50th percentile
level (5.6 mg/dL) at the third and fourth days and returned to the
24-hour level (4.8 mg/dL) at the sixth day. The 95th percentile bilirubin
level was 8.2mg/dL at 24 hours of life, reached 12.2mg/dL on the fourth
day, and declined to 8.5 mg/dL on the 12th day.
CONCLUSIONS: The transcutaneous bilirubin curve represents the
natural history of bilirubinemia in exclusively breastfed healthy term
newborns in the ﬁrst 12 days of life. Pediatrics 2011;128:e565–e571
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Approximately 70% of term newborns
present with jaundice in the ﬁrst week
of life, and in most cases this jaundice
it is a transient and benign phenome-
non. However, the serumbilirubin level
that is considered physiologically nor-
mal is not well known and depends
mainly on the ethnic and racial distri-
bution of the population and on the
type of feeding provided in the ﬁrst
days of life, in addition to other epide-
miological factors.
The temporal evolution of neonatal bil-
irubinemia was initially investigated in
the United States in a longitudinal
study with 29 term newborns. The re-
sults of this study showed that the bil-
irubin level has a mean peak at day 3
and drops on days 4 and 5 to a level
similar to that of the ﬁrst day of life.2
Later, results of studies performed
with term and near-term neonates in
Canada,3 Nigeria,4 Japan,5 Israel,6 Tur-
key,7 Thailand,8 Italy,9 and Greece10 ver-
iﬁed that the serum bilirubin (SB) or
transcutaneous bilirubin (TcB) could
be elevated even at the ﬁfth or sixth
day of life during hospitalization, with
the mean and maximum peaks occur-
ring between the third and sixth days
of life. It was not possible, however, to
determine the magnitude and time of
the decrease in bilirubin levels. De
Luca et al11 compared 4 TcB nomo-
grams and showed that the bilirubin
rates of increase tended to plateau at
96 hours of life, with some differ-
ences between populations. Maisels
and Kring12 studied the natural course
of neonatal bilirubinemia in the ﬁrst 96
hours of life in newborns of 35 or more
weeks of gestation and demonstrated
the progression of the mean TcB to 8
mg/dL at the end of the study period;
nonetheless, these investigators ob-
served that the mean peak was not
reached in the ﬁrst 96 hours of life.
Engle et al13 followed Hispanic new-
borns of 35 ormoreweeks of gestation
for up to 72 hours of life and found a
progressive increase in TcB, with the
95th percentile of 12.4 mg/dL occur-
ring at 72 hours of life.
Currently, there is much concern
about the association of hyperbiliru-
binemia levels above 25 mg/dL and
breastfeeding.14 In the United States in
2005, 72% of children had any breast-
feeding in the ﬁrst 14 days of life,15
whereas in Brazil in 2008, 67% of new-
borns were exclusively breastfed for
up to 15 days of life.16 In this context, it
is important to understand the behav-
ior of physiological bilirubin values to
educate mothers about hyperbiliru-
binemia during their hospital stay and
after their hospital discharge in a
follow-up program.
Given the good correlation between SB
and TcB in healthy newborn infants of
diverse races and ethnicities,17 as well
as lack of knowledge about biliru-
binemia in the second week of life, this
study was conducted to measure TcB
levels and construct a curve to demon-
strate the behavior of TcB levels during
the ﬁrst 12 days of life in healthy, exclu-
sively breastfed term neonates who
did not need phototherapy.
PATIENTS AND METHODS
The present study was designed as a
prospective cohort study conducted at
a public secondary maternity hospital
with 4800 births per year in the state of
São Paulo, Brazil. The project was ap-
proved by the research ethics commit-
tee of the Universidade Federal de São
Paulo, and written informed consent
was obtained from parents of the en-
rolled infants.
Patients whomet the inclusion criteria
for the study were singleton infants
born after a gestation of 37 to 41
weeks who were appropriate for ges-
tational age,18 born at the hospital
with an Apgar score of 7 or above at
5 minutes, exclusively breastfed,19
roomed-in for at least 48 hours, and
followed up at home for up to 12 days
of life. All patients were born on Thurs-
days or Fridays between 8 AM and 6
PM, in the period between August 2000
and February 2001, to allow for the
same researcher (Dr Draque) to make
a longitudinal evaluation of each
newborn.
The exclusion criteria for neonates
were positive indirect Coombs test in
the maternal serum or positive direct
Coombs test in the umbilical cord
blood, presence of cephalohematoma
or ecchymosis, and having received
phototherapy. The direct Coombs test
is part of routine care at the institu-
tion. Glucose-6-phosphate dehydroge-
nase wasmeasured in all patients, and
those with a deﬁciency of this enzyme
were excluded.
The maternal and neonatal character-
istics that may have affected the
course of bilirubinemia were re-
corded. Patients were weighed every
day by the rooming-in nursing team,
and after hospital discharge, the
weight was measured by the re-
searcher (Dr Draque) at home, daily
from the third to the sixth days, and at
the eighth, 10th and 12th days. Weight
loss was calculated as the daily weight
minus the birth weight divided by the
birth weight. The infants were weighed
on a digital balance (Filizola, São Paulo,
Brazil) in the hospital and on another
digital balance from the same manu-
facturer in the newborn’s house.
TcBwas measured in each neonate at
days 1, 2, 3, 4, 5, 6, 8, 10, and 12 of life.
The ﬁrst 2 or 3 measurements were
obtained during the rooming-in, and
the others at the newborn’s home.
TcB was measured on the forehead
of each patient by use of the BiliCheck
spectrophotometric method (SpectRx
Inc, Norcross, GA) with individual BiliCal
calibration tips (SpectRx Inc, Norcross,
GA). When the TcB level obtained was
15mg/dL, theSBwasmeasuredbyuse
of the Jendrassik Grof method, accord-
ing to Bhutani et al.17
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If the result of 15 mg/dL for the TcB
level was conﬁrmed, the infant was
submitted to a diagnostic evaluation of
hyperbilirubinemia and to photother-
apy, and was excluded from the study.
After the 12th day of life, if the TcB level
was 6 mg/dL, the infant was evalu-
ated every 3 days until the TcB level
was5 mg/dL.
Blood samples were drawn from the
heel at 48 to 72 hours to determine the
correlation between capillary bilirubin
levels and TcB levels with the Pear-
son’s coefﬁcient at the same time that
hematocrit was determined.
The clinical data have been analyzed
with the2 test, Fisher’s exact test, and
the Student’s t test, as appropriate.
In theory, the function that represents
the change in bilirubin levels in neo-
nates over time should be nonlinear.11
This curve should show an increase
during the ﬁrst days of life and then
decrease to a stable level (an asymp-
tote). Multiple curve-estimation proce-
dures were performed to ﬁnd the best-
ﬁtting mathematical model, and a
third-degree polynomial function of
time was used to describe trends in
the bilirubin levels over time for data
that included bilirubin levels obtained
for each individual neonate on 9 occa-
sions TcB  3.9027  [1.1518  d]
[0.229  d2]  [0.0107  d3]; R2 
0.6475, where d is days. The data were
analyzed with SAS 9.2 (SAS Institute,
Inc, Cary, NC) for Windows.
RESULTS
During the 7-month data collection pe-
riod, 253 newborns fulﬁlled the inclu-
sion criteria up to 48 to 72 hours of life,
and 30 were not able to be followed up
at home. Seventeen patients had incor-
rect addresses, 9 received photother-
apy during the hospital stay (SB: 14.5–
19.0 mg/dL at 48 hours of life), 2
patients received phototherapy during
home follow-up visits at days 4 and 5 of
life (SB: 16.0 and 18.3 mg/dL, respec-
tively), 1 neonate was fed with formula
from the fourth day of life, and 1 had a
deﬁciency of glucose-6-phosphate de-
hydrogenase. Thematernal and neona-
tal characteristics of the 223 included
patients and of the 30 excluded pa-
tients were similar.
Table 1 displays the maternal and neo-
natal characteristics of 223 patients
included in the study. The mothers of
148 neonates (66%) breastfed in the
ﬁrst hour after birth, and 62 (44%)
started breastfeeding at the third to
fourth hour of life. The 223 newborns
remained exclusively breastfed and
were discharged at 52  6 hours of
life. The maximum weight loss in rela-
tion to birth weight was 4.7%  2.0%
(range: 1%–12%) between the second
and third days of life, and 132 patients
(59%) recovered their birth weight by
the ﬁfth day of life. The 223 newborns
gained 43  15 g per day (range:
10–85 g) from the lowest weight re-
corded up to the 12th day of life, and 13
(6%) did not return to their birth
weight during the period of the study
(Fig 1).
The TcB and SB levels were highly
correlated: the Pearson’s correlation
coefﬁcient was 0.96 (95% conﬁdence
interval: 0.95–0.97). The mean hemat-
ocrit at 48 to 72 hours of life was
61.9% (95% conﬁdence interval:
61.1%–62.7%).
On the basis of the 2007 TcB measure-
ments in the 223 patients who were
followed up to 12 days of life, a 50th-
percentile TcB curve was constructed
as a function of time with the 25th,
75th, 90th, and 95th percentiles (Table
2 and Fig 2). The highest 50th percen-
tile TcB level was 5.6 mg/dL, which was
observed between the third and fourth
days of life. The highest 95th percentile
value was 12.2 mg/dL, which was ob-
served on the fourth day of life.
On the sixth day of life, the 50th percen-
tile of the TcB level dropped to the
value of the ﬁrst day of life (4.8 mg/dL).
The 95th percentile value obtained up
TABLE 1 Maternal and Neonatal Characteristics of 223 Patients Included in the Study
Characteristic Value
Maternal age, mean SD, y 24 6
Race, n (%)
White 102 (46)
Mixed race 77 (34)
Black 44 (20)
Years of school, mean SD, y 7 3
First gestation, n (%) 91 (41)
Prenatal care, n (%) 220 (99)
Maternal hypertension, n (%) 17 (8)
Maternal diabetes, n (%) 2 (1)
Previous newborn with jaundice, n (%) 21 (16)
Use of tobacco, n (%) 45 (20)
Oxytocin, n (%) 129 (58)
Anesthesia with bupivacaine, n (%) 63 (28)
Vertex presentation, n (%) 217 (97)
Meconium-stained amniotic ﬂuid, n (%) 36 (16)
Vaginal delivery, n (%) 166 (74)
Birth weight, mean SD, g 3262 329
Gestational age, mean SD, wk 39.4 1.1
Male gender, n (%) 114 (51)
Apgar score at 1 min, mean SD 8.0 1.0
Apgar score at 5 min, mean SD 9.0 0.3
ABO incompatibility, n (%) 27 (12)
Rooming-in at ﬁrst hour of life, n (%) 158 (71)
Breastfeeding in ﬁrst hour of life, n (%) 148 (66)
Passage of ﬁrst stool, mean SD, h 6 7
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to the 12th day of life remained higher
than the level at the ﬁrst day of life.
On the 12th day of life, 41 newborns
(18%)presentedwith a TcB level6mg/
dL, which reached lower levels, on aver-
age, at 21 days of life (range: 15–42 days).
At 30 days of life, 3 infants (1.3%) were
breastfed and still jaundiced, with amean
TcB level of 8.8mg/dL (measured levels for
each infant: 8.3, 8.7, and 9.3mg/dL).
DISCUSSION
The results of this study show the rise
and the fall of TcB levels in healthy
term newborns who were exclusively
breastfed, most of whom recovered
birth weight on the ﬁfth day of life. The
unique features of this study were
that data collection was longitudinal
for the same infants rather than
cross-sectional and that TcB levels
were measured until the infants
were 12 days old. To our knowledge,
there have been no studies on jaun-
dice in neonates who were exclu-
sively breastfed and whose weight
changes were monitored for up to 12
days of life.
In some studies conducted in other
countries, investigators have consid-
ered amaximumof 96 hours of life dur-
ing the hospital stay and showed a rise
in total bilirubin levels, but did not de-
tect the drop.8,9,12,13 In 2 reported stud-
ies7,10 nomograms of TcB and SB levels
for the ﬁrst 5 to 7 days of life showed
that TcB levels decreased as of the
fourth day of life in term neonates.
Previously reported studies have in-
cluded nomograms based on mea-
surements of TcB levels that were ob-
tained from term neonates during the
ﬁrst 3 to 4 days of life,8 healthy infants
aged 35 weeks during the ﬁrst 96
hours,12 term neonates for up to the
ﬁrst 96 hours,9 term neonates for the
ﬁrst 12 to 120 hours,10 and Hispanic
neonates aged 35 weeks during the
ﬁrst 72 hours of life.13
In the present study of 223 term new-
borns, 54% of them were mixed race
and black, but none were of Asian eth-
nicity. The highest mean value (50th
percentile) of the total bilirubin level
TABLE 2 Total Bilirubin Percentiles in the 223 Exclusively Breastfed Healthy Term Newborns in the
First 12 Days of Life
Postnatal
Age, d
Postnatal Age, Mean
(95% Conﬁdence Interval), h
Total Bilirubin Percentiles, mg/dL
25th 50th 75th 90th 95th
1 26.7 (26.0–27.4) 3.5 4.8 6.2 7.4 8.2
2 50.1 (49.4–50.8) 3.3 5.3 7.4 9.3 10.4
3 75.4 (74.7–76.1) 3.0 5.6 8.2 10.5 11.9
4 99.3 (98.6–100) 2.8 5.5 8.3 10.7 12.2
5 123.4 (122.7–124.1) 2.6 5.2 8.0 10.4 11.8
6 147.4 (146.7–148.1) 2.2 4.9 7.6 10.1 11.5
8 195.4 (194.7–196.1) 1.4 4.0 6.5 8.8 10.2
10 243.3 (242.6–244.0) 0.9 3.3 5.6 7.7 8.9
12 291.0 (290.3–291.7) 1.2 3.3 5.4 7.3 8.5
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FIGURE 1
Body weight percentiles (P) in the 223 exclusively breastfed healthy term newborns in the ﬁrst 12 days of life.
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was 5.6 mg/dL and occurred between
the third and fourth days of life. This
value was close to that reported for
formula-fed newborns, which was
roughly 6 mg/dL.2,3 Some investiga-
tions conducted in newborns in North
America, Africa, Asia, and Europe
showed mean total bilirubin-level
peaks that ranged from 7.5 to 12.0
mg/dL between the third and sixth
days of life. Some studies included
newborns who were exclusively
breastfed, some who were on formula,
and others on mixed feeding.3–5,7–10,12
In the present study, the 95th percen-
tile of the TcB level reached 12.2 mg/dL
on the fourth day of life, which is a
value similar to that obtained by the
National Collaborative Perinatal Proj-
ect of 12.9 mg/dL, in a study conducted
when the use of formula for feeding
infants predominated,20 and by 2 other
studies, 1 in which 67%12 and another
in which 32% of patients breastfed.13
However, 95th percentile values of 15
mg/dL have been reported in European
investigations.9,10 The lowest total bili-
rubin levels found in the present study
could be associated with appropriate
breastfeeding practices, as demon-
strated by the mean maximum weight
loss of 4.7%  2.0% between the sec-
ond and third days of life and by the
recovery to the birth weight at 5 days
in most newborns. Among the 223 pa-
tients, 66% initiated breastfeeding in
the delivery room, and all were breast-
fed in the rooming-in period for at
least 48 to 72 hours of life; with breast-
feeding during the rooming-in period,
which is recommended by the World
Health Organization, mothers could
better understand the technique, and
this led to successful breastfeeding.21
The volume of milk produced by the
nursing mother is closely related to
when breastfeeding begins, breast-
feeding frequency, complete emptying
of the breast, and ability of the new-
born to effectively suck. Hence, initia-
tion of breastfeeding in the ﬁrst hour
of life, followed by nursing 10 to 12
times per day in the ﬁrst week, with no
other supplementation of water or
other foods, together with appropriate
breastfeeding techniques that ensure
effective provision of milk to the neo-
nate, minimize weight loss to 7%,
and keep bilirubin levels low.22,23,24 Al-
though the number of times of breast-
feeding was not recorded in this study,
the weight recovery in the ﬁfth day of
life and the maximum weight loss of
12% in 1 infant could be indicative of
appropriate breastfeeding.
On the sixth day of life, the mean total
bilirubin level returned to 4.8 mg/dL,
which was the value detected on the
end of the ﬁrst day. Few authors have
investigated the decrease in biliru-
binemia during the neonatal period. In
2 studies, 1 with 29 patients and an-
other with 39 North American formula-
fed newborns, bilirubinemia of 3
mg/dL occurred on the sixth day, a
level similar to that of the ﬁrst day, and
bilirubinemia of 1 mg/dL occurred at
11 days of life.2,25 Studies in breastfed
newborns revealed mean estimated
bilirubin levels of 5 to 7 mg/dL at the
end of the ﬁrst week of life and of 3 to 5
mg/dL at the end of the ﬁrst month.25 In
a sample of 336 Japanese newborns,
the mean values were 12.3 mg/dL at 7
days and 7.6 mg/dL at 30 days of life,
values that did not reach the levels of
the ﬁrst day of life,5 and the 95th per-
centile values remained higher as of
the 12th day comparedwith those as of
the ﬁrst day of life.
In the present study, 41 patients (18%)
had bilirubinemia levels of 6 mg/dL
at 12 days of life and took, on average,
21 days (range: 15–42 days) to achieve
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FIGURE 2
TcB percentiles (P) in the 223 exclusively breastfed healthy term newborns in the ﬁrst 12 days of life.
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bilirubinemia lower than 6 mg/dL,
which conﬁrmed the ﬁnding that 20%
to 30% of newborns remained clini-
cally icteric for 2 to 3 weeks.25–27 This
slower drop in bilirubin levels has
been attributed to breastfeeding, but
the exact mechanism that causes the
prolonged hyperbilirubinemia still
needs to be identiﬁed. The existence of
a substance in maternal milk is specu-
lated, which would inhibit glucuronyl
transferase or increase the enterohe-
patic circulation of bilirubin.26 Gourley
et al28 reported that transcutaneous
bilirubin in breastfed term newborns
remained higher (8 mg/dL) than the
initial values for up to 20 days of life.
In patients fed with whey-protein for-
mulas, values similar to the initial
levels of 5 mg/dL were measured at
20 days; moreover, in a third group
fed with casein, the initial bilirubin
level was achieved at 10 days of life.
The authors speculated that this
faster drop could be explained by the
fact that casein-formulas contain a
-glucuronidase inhibitor, which de-
creases the enterohepatic circula-
tion of bilirubin. In addition to this
possibility, in a recent Taiwan study
investigators demonstrated the as-
sociation between prolonged indirect
hyperbilirubinemia in breastfed new-
borns and a mutation in the uridine
diphosphate-glucuronosyltransferase
(UGT1A1) gene.29
The main limitation of this study was
its application to other populations
and ethnicities. It is necessary to con-
ﬁrm whether low total bilirubin levels
can be found in areas where exclusive
breastfeeding is a predominant prac-
tice in the ﬁrst month of life. Further-
more, in the present investigation,
near-term newborns of 35 to 36 weeks
of gestation were not evaluated, and
patients requiring phototherapy were
excluded. One study that includedmea-
surement of TcB levels until initiation
of phototherapy showed 95th percen-
tile values of 15 mg/dL,11 but studies
without patients treated with photo-
therapy revealed 90th to 95th percen-
tile values from 12 to 13 mg/dL,12,13
which were similar to our ﬁndings.
With the use of the values of bilirubin
recommended by the American Acad-
emy of Pediatrics (2004)24 as indica-
tors to initiate phototherapy, it was
only in 2 patients in this study that the
treatment was not indicated. This
small number should not have materi-
ally affected the outcome. Further-
more, patients with some major risk
factors for the development of severe
hyperbilirubinemia, such as hemolytic
disease because of blood group incom-
patibility with positive direct Coombs,
glucose-6-phosphate dehydrogenase
deﬁciency, cephalohematoma, or sig-
niﬁcant bruising, were excluded. These
stringent inclusion criteria may have
biased our results.
CONCLUSIONS
On the basis of the results of this study,
we conclude that in healthy, term, ex-
clusively breastfed neonates born pre-
dominantly by vaginal delivery with
good health conditions at birth who
stayed in rooming-in for at least 48
hours, the weights returned to the
birth weights at 5 days of life. We ob-
served mean bilirubin levels of 5.6 mg/
dL, and the 95th percentile of 12.2
mg/dL between the third and fourth
days of life showed a progressive de-
cline, achieving the values found at the
end of the ﬁrst 24 hours on the sixth
day of life. These data are useful for
clinicians who educate parents about
the natural history of bilirubinemia
and the importance of appropriate
breastfeeding in term newborns.
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